(ALLE-Z)-5,8,11,14,17-EICOSAPENTAENSAEURE UND/ODER DEREN DERIVATE ENTHALTENDE FORMULIERUNGEN, SOWIE VERFAHREN ZU IHRER HERSTELLUNG

A pharmaceutical composition contains (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides and a pharmaceutically acceptable vehicle. The (all-Z)-5,8,11,14,17-eicosapentaenoic acid or its pharmaceutically acceptable salts, esters or amides can...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OLAF BANG,HANS, DYERBERG,JOERN, ROBERT VANE,JOHN, ENRIQUE MONCADA,SALVADOR
Format:	Patent
Sprache:	ger
Schlagworte:	DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKINGOILS FOODS OR FOODSTUFFS HUMAN NECESSITIES HYGIENE MAKING THEREOF MEDICAL OR VETERINARY SCIENCE MILK OR CHEESE SUBSTITUTES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A pharmaceutical composition contains (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides and a pharmaceutically acceptable vehicle. The (all-Z)-5,8,11,14,17-eicosapentaenoic acid or its pharmaceutically acceptable salts, esters or amides can be used for the treatment or prophylaxis of thromboembolic states, to increase the bleeding time, dissolve or disperse thrombi or platelet aggregates which have already formed or to modify or prevent the adhesion of platelets to damaged tissue. They can furthermore be used to treat platelets in order to reduce their tendency to aggregation and/or to increase the rate of their separation from one another. They can furthermore be used as additive to blood in an extracorporeal circulation.